Epidemiology


Etiology


Pathophysiology


Clinical features

  • History:
    • Recurrent binge eating episodes: Consuming an objectively large amount of food in a discrete period (< 2 hours) with a perceived lack of control.
    • Inappropriate compensatory behaviors to prevent weight gain: Self-induced vomiting, misuse of laxatives/diuretics/enemas, fasting, or excessive/driven exercise. c
    • Frequency: Episodes occur at least once weekly for ≥ 3 months.
    • Excessive preoccupation with body shape and weight dictates self-worth.
    • Behaviors typically kept secretive; patients often feel guilt/shame after binges.
  • Physical Examination:
    • BMI: Typically normal or slightly overweight (BMI ≥ 18.5 kg/m²).
    • HEENT: Bilateral parotid gland enlargement (sialadenosis), subconjunctival hemorrhages (from increased intrathoracic pressure during vomiting).
    • Oral: Dental erosion (perimylolysis—loss of enamel on lingual surfaces of anterior teeth), extensive dental caries.
    • Dermatologic: Russell sign (calluses, abrasions, or scars on dorsal surface of hand/knuckles from manual induction of gag reflex).
    • Abdomen: Epigastric tenderness (gastritis, GERD).

Diagnostics

  • ↓ Potassium, ↓ sodium, ↓ chloride, and ↓ calcium
  • Metabolic alkalosis
  • Possible ↑ serum α-amylase

Differential diagnostics


Treatment

  • Acute / Stabilization:
    • IV normal saline + KCl repletion.
    • Hospitalize if: Severe electrolyte derangement (K < 3.0 mEq/L), hemodynamic instability, or cardiac arrhythmias.
  • First-Line:
    • CBT (most effective psychotherapy) + Fluoxetine (60 mg/day; only FDA-approved SSRI). c
  • Second-Line:
    • Alternative SSRI (e.g., Sertraline) or Topiramate.
  • BLACK BOX / CONTRAINDICATION:
    • Bupropion is strictly contraindicated (high seizure risk in purging pts).

Warning

The antidepressant bupropion lowers the seizure threshold and is contraindicated in individuals with a history of anorexia nervosa, bulimia nervosa, or purging behaviors.